Exemplos de uso de Double-blind phase em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Study n=population in double-blind phase; n=population in maintenance phase. .
Patients who identified an effective dose entered the double-blind phase of the study.
The patients entering the double-blind phase treated up to 10 episodes of BTP with either PecFent(7 episodes) or placebo(3 episodes) in a random order.
Both IELT andIPE scores continued to increase slightly more throughout the remainder of the double-blind phase.
Table 8: Summary of efficacy results- studies MDS-004(double-blind phase) and MDS-003, intent-to- treat population.
There was also seen a reduction in triglycerides in controls in the open phase of the study compared to the last double-blind phase.
During the 24-week double-blind phase, patients received either 5 mg/ kg infliximab or placebo at weeks 0, 2, 6, 14, and 22 100 patients.
Another secondary endpoint evaluated the proportion of patients with≥3 RFBMs per week during the 4-week double-blind phase.
During the 16-week double-blind phase, patients received either 5 mg/kg infliximab or placebo at weeks 0, 2, 6, and 14 52 patients in each group.
Of the eight subjects included,five completed the open phase of induction and the double-blind phase, extension open-label phase. .
In the first study(P01522), which had a 3 month double-blind phase, 70 patients received either 5 mg/kg infliximab or placebo at weeks 0, 2, 6 35 patients in each group.
Table 5: Treatment-emergent laboratory test abnormalities reported in placebo-controlled phase III trial(double-blind phase) in patients with GIST GRID.
The relative contributions of previous placebo treatment in the double-blind phase and of other medications started during the open- label extension period are unknown.
In the Phase III study, 69 patients were on lenalidomide 5 mg, 69 patients on lenalidomide 10 mg and67 patients were on placebo during the double-blind phase of the study.
The other visits included a total of 30 serial evaluations, monthly,within 6 months of the double-blind phase, and quarterly in the evaluations that followed during the open-label extension.
In some studies, the double-blind phase was followed by an open- label phase during which all patients received epoetin alfa and a maintenance of effect was observed.
The efficacy and safety of apixaban in the primary prevention of VTE in patients who underwent hip and knee prosthesis were assessed in three controlled,randomized, double-blind, phase III clinical studies, entitled ADVANCE 1-3.
Dexmethylphenidate was assessed in a randomized controlled double-blind phase II study that consisted of assessment of 154 patients with fatigue that received at least four cycles of CT for treatment of breast and ovarian cancer, predominantly.
In a randomised trial of 318 hypertensive children andadolescents aged 6 to 16 years, the following adverse reactions occurred in the 3-week double-blind phase: headache(7.9%), hypotension(2.2%), dizziness(1.9%), cough 0.9.
The TRITON-TIMI 38 trial, a randomized, double-blind, phase III study, showed significant risk reduction in the study primary endpoints nonfatal MI, nonfatal CVA and cardiovascular death in patients treated with Prasugrel 10 mg daily when compared to those treated with clopidogrel 75 mg daily 9.9% versus 12.1%, p.
Improvements in functioning, as measured by the Personal and Social Performance scale(PSP),which was observed during the open-label stabilisation phase were maintained during the double-blind phase for both treatment groups.
The primary efficacy endpoint of the study was the percentage of subjects who had not relapsed at the end of the 48-week double-blind phase based on the Kaplan-Meier 48-week estimate TREVICTA: 91.2%, 1-monthly paliperidone palmitate injectable: 90.0.
The first co-primary endpoint was the proportion of patients having a rescue free bowel movements(RFBMs) within 4 hours of the first dose administration andthe second the percentage of active injections resulting in any RFBM within 4 hours during the double-blind phase.
During the double-blind phase of the long-term randomised withdrawal study, elevations of prolactin to above the reference range(> 13.13 ng/ml in males and> 26.72 ng/ml in females) were noted in a higher percentage of males and females in the TREVICTA group than in the placebo group 9% vs.
A total of 410 stabilised patients were randomised to either Xeplion(median duration 171 days[range 1 day to 407 days]) or to placebo(median duration 105 days[range 8 days to 441 days])until they experienced a relapse of schizophrenia symptoms in the variable length double-blind phase.
The effects of Pravafenix 40 mg/160 mg were confirmed in a similar multicenter,64-week trial including a 12 week randomized, double-blind phase in a study performed in the USA and comparing Pravafenix 40 mg/160 mg to Fenofibrate 160 mg monotherapy and Pravastatin 40 mg monotherapy in patients with mixed dyslipidaemia.
The CHMP assessed the“ Relapse Prevention Study”(12 weeks of open-label and single-blind risperidone treatment followed by a 6-month double-blind) andwas of the opinion that it may only be considered as supportive, due to the fact that only responders entered the double-blind phase.
The most important studies that analyzed the efficacy and safety of rivaroxaban for the primary prophylaxis of VTE in knee and hip replacement surgeries are the RECORD 1-4 controlled,randomized, double-blind, phase III studies. The primary event was total VTE, including PTE, proximal and distal, symptomatic and asymptomatic DVT as assessed by venography, and all-cause mortality.
One hundred and seventy-eight visits were assessed of eight patients with JIA who participated in a controlled clinical phase III trial testing the efficacy and safety of abatacept and using the same evaluations at intervals of four to 12 weeks of the original trial, a withdrawal study design,which included an open-label phase of 4 months, double-blind phase trial open-label extension phase of up to 5 years.
The efficacy of ticagrelor was evaluated by the"Platelet Inhibition and Patient Outcomes PLATO" trial, a multicenter,randomized, double-blind phase III trial comparing the efficacy of ticagrelor loading dose of 180 mg followed by administration of 90 mg twice daily compared to clopidogrel loading dose of 300 mg followed by daily administration of 75 mg.